Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.098 | 0.8 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |